"Pathways": A hope-enhancing intervention for patients undergoing treatment for advanced lung cancer.

ABSTRACT:

Objective

Observational data suggest hope is associated with the quality of life and survival of people with cancer. This trial examined the feasibility, acceptability, and preliminary outcomes of "Pathways," a hope intervention for people in treatment for advanced lung cancer.

Methods

Between 2020 and 2022, we conducted a single-arm trial of Pathways among participants who were 3-12 weeks into systemic treatment. Pathways consisted of two individual sessions delivered during infusions and three phone calls in which participants discussed their values, goals, and goal strategies with a nurse or occupational therapist. Participants completed standardized measures of hope and goal interference pre- and post-intervention. Feasibility was defined as ≥60% of eligible patients enr

SUBMITTER: McLouth LE 

PROVIDER: S-EPMC11157457 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature